Medical therapy for ulcerative colitis

S. B. Hanauer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Last year was not a banner year for developments in medical therapy for ulcerative colitis. In contrast to the expansion of therapies for Crohn disease, treatment for ulcerative colitis was evolutionary, at best, leading many patients to seek alternative medical approaches. Nevertheless, there have been advances in the application of aminosalicylates and immune modifiers for ulcerative colitis. Additional, nonconventional approaches include nicotine, probiotics, dietary therapies, and heparins. Several novel approaches have arisen from animal models, including additional means of inhibiting nuclear factorκB and targeting of tumor necrosis factor-α.

Original languageEnglish (US)
Pages (from-to)324-328
Number of pages5
JournalCurrent Opinion in Gastroenterology
Volume16
Issue number4
DOIs
StatePublished - Dec 1 2000

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Medical therapy for ulcerative colitis'. Together they form a unique fingerprint.

Cite this